Review · Volume 5, Issue 1 · pp. 16–20

Gastroprotective agents use with Nonsteroidal Antiinflammatory Drugs: an Overview

Mahendra Kumar BJ¹, Naveen KHD¹, Chakrapani K¹, Sowmya M¹

¹Department of Pharmacy Practice, SAC College, BG Nagara - 571448, Karnataka, India.

Abstract

Non-steroidal Anti-inflammatory Drugs (NSAIDs) are widely used in clinical set up for patient care because of their analgesic, anti-inflammatory and antipyretic properties. Most of the NSAIDs can cause gastrointestinal damage by inhibiting cyclooxygenase-1 (COX-1) enzyme. Strategies are recommended to reduce the risk of NSAIDs associated gastrointestinal (GI) adverse events. Prevention of GI morbidity induced by NSAIDs with co-prescription of Gastro protective agents (GPA) has been clinically approved. Administration of GPA in all NSAIDs users is unnecessary. Selection of GPA mainly depends upon the NSAID related GI risk and also the patient risk factor for GI complication as well as efficacy and tolerability of both NSAID and GPA.

Keywords: Non-steroidal Anti-inflammatory Drugs; Gastrointestinal; Gastro protective agents

The full text of this article is available as a PDF. Open the PDF.